Longevity

February 14, 2019

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA DANCR inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 14/February/2019, 6.48 am

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA DANCR inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 14/February/2019, 6.48 am https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-DANCR-promotes-lifespan-through-up-regulation-of-PARP1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-DANCR-promotes-lifespan-through-up-regulation-of-PARP1.jpg February 14, 2019 February 14, 2019

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

February 12, 2019

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA PCGEM1 (Prostate-specific transcript 1) inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and ageing, via down-regulation of its target gene, 12/February/2019, 11.14 pm

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA PCGEM1 (Prostate-specific transcript 1) inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and ageing, via down-regulation of its target gene, 12/February/2019, 11.14 pm https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-PCGEM1-promotes-lifespan-through-up-regulation-of-PARP1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-PCGEM1-promotes-lifespan-through-up-regulation-of-PARP1.jpg February 12, 2019 February 12, 2019

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

January 29, 2019

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA ARNILA (AR negatively induced lncRNA) inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 29/January/2019, 6.35 am

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA ARNILA (AR negatively induced lncRNA) inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 29/January/2019, 6.35 am https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-ARNILA-protects-against-cancer-and-premature-ageing.-And-thereby-promotes-health.lifespan.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-ARNILA-protects-against-cancer-and-premature-ageing.-And-thereby-promotes-health.lifespan.jpg January 29, 2019 January 29, 2019

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

January 28, 2019

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA NEAT1 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 29/January/2019, 5.23 am

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA NEAT1 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 29/January/2019, 5.23 am https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-NEAT1-protects-against-cancer-and-pre-mature-ageing.-And-thereby-promotes-healthlifespan2.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-NEAT1-protects-against-cancer-and-pre-mature-ageing.-And-thereby-promotes-healthlifespan2.jpg January 28, 2019 January 28, 2019

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

January 17, 2019

RNA-based therapy for aging-associated diseases and Lifespan extension: LncRNA UCA1 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging, via down-regulation of its target gene, 18/January/2019, 12.04 am

RNA-based therapy for aging-associated diseases and Lifespan extension: LncRNA UCA1 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging, via down-regulation of its target gene, 18/January/2019, 12.04 am https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-UCA1-Urothelial-cancer-associated-1-protects-against-premature-ageing.-And-thereby-promotes-health.lifespan.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-UCA1-Urothelial-cancer-associated-1-protects-against-premature-ageing.-And-thereby-promotes-health.lifespan.jpg2_.jpg January 17, 2019 January 17, 2019

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

January 17, 2019

RNA-based therapy for aging-associated diseases and Lifespan extension: LncRNA MALAT/NEAT2 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging, via down-regulation of its target gene, 17/January/2019, 11.48 pm

RNA-based therapy for aging-associated diseases and Lifespan extension: LncRNA MALAT/NEAT2 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging, via down-regulation of its target gene, 17/January/2019, 11.48 pm https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-MALAT.NEAT2-Metastasis-associated-lung-adenocarcinoma-transcript-1-protects-against-cancer-and-premature-ageing.-And-thereby-promotes-health.lifespan.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-MALAT.NEAT2-Metastasis-associated-lung-adenocarcinoma-transcript-1-protects-against-cancer-and-premature-ageing.-And-thereby-promotes-health.lifespan.jpg January 17, 2019 January 17, 2019

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

Previous
1
…
7
8
9
10
11
…
51
Next